v3.22.1
Statements of Stockholders' Deficit - USD ($)
Common Stock
Common Shares to be Issued
Additional Paid in Capital
Accumulated Deficit
Total
Balances at Dec. 31, 2019 $ 257,301 $ 664,099 $ (1,159,456) $ (238,056)
Balances (in Shares) at Dec. 31, 2019 257,301,000      
Finance cost for issuance of common shares for note modification $ 200 11,800 12,000
Finance cost for issuance of common shares for note modification (in Shares)   200,000      
Beneficial conversion feature related to convertible notes 162,473 162,473
Net loss (81,174) (81,174)
Balances at Dec. 31, 2020 $ 257,301 $ 200 838,372 (1,240,630) (144,757)
Balances (in Shares) at Dec. 31, 2020 257,301,000 200,000      
Conversion of convertible note payable to common stock $ 12,500 12,500
Conversion of convertible note payable to common stock (in Shares) 12,500,000      
Stock payable issued $ 200 $ (200)
Stock payable issued (in Shares) 200,000 (200,000)      
Conversion of convertible note payable to common stock 1 $ 14,000 14,000
Conversion of convertible note payable to common stock 1 (in Shares)   14,000,000      
Beneficial conversion feature related to convertible notes 8,000 8,000
Net loss (164,432) (164,432)
Balances at Dec. 31, 2021 $ 270,001 $ 14,000 $ 846,372 $ (1,405,062) $ (274,689)
Balances (in Shares) at Dec. 31, 2021 270,001,000 14,000,000